Maravai LifeSciences Holdings, Inc. MRVI Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 18.3%-23.5pp | 41.8%-6.7pp | 48.5%-32.3pp | 80.9%-1.5pp | |
| Operating margin | -115.9%-25.0pp | -90.9%-80.0pp | -11%-76.0pp | 65%-4.4pp | |
| Net margin | -70.4%-14.5pp | -55.9%-14.7pp | -41.2%-66.1pp | 24.9%+2.2pp | |
| EBITDA margin | -88.2%-15.9pp | -72.2%-75.2pp | 3%-65.7pp | 68.6%-3.9pp | |
| Free cash flow margin | -38.1%— | —— | —— | 58.8%+14.5pp | |
| Returns | |||||
| Return on equity | -48.6%-9.6pp | -39%-14.3pp | -24.7%-75.9pp | 51.2%-38.9pp | |
| Return on assets | -14.7%-3.1pp | -11.6%-5.3pp | -6.3%-16.8pp | 10.5%-0.9pp | |
| Return on invested capital | -58.2%-1.6pp | -56.6%-53.3pp | -3.3%-125pp | 122%-3.4pp | |
| Efficiency | |||||
| Asset turnover | 0.2×0.0× | 0.2×+0.1× | 0.2×-0.3× | 0.4×-0.1× | |
| Inventory turnover | 3.4×+0.4× | 3×-0.2× | 3.1×-0.4× | 3.6×+0.3× | |
| Liquidity | |||||
| Current ratio | 6.6×-0.9× | 7.5×-0.5× | 8×+0.3× | 7.7×-0.2× | |
| Quick ratio | 5.7×-1.0× | 6.7×-0.8× | 7.4×+0.1× | 7.3×0.0× | |
| Cash ratio | 4.8×-0.8× | 5.7×-0.9× | 6.6×+0.8× | 5.7×-0.1× | |
| Leverage | |||||
| Debt-to-equity | 1.7×+0.6× | 1.2×-0.3× | 1.5×+0.4× | 1.1×-0.7× | |
| Debt-to-assets | 0.5×+0.1× | 0.4×0.0× | 0.4×+0.2× | 0.3×0.0× | |
| Interest coverage | -8×-3.0× | -4.9×-4.3× | -0.7×-28.8× | 28.1×+9.8× | |
| Per Share | |||||
| Book value per share | $1.47-37.6% | $2.36-25.3% | $3.16+47.9% | $2.14+74.5% | |
| Valuation | |||||
| Market capitalization | $849.64M+204% | $773.05M-53.1% | $1.65B-54.0% | $3.59B-82.4% | |
| Enterprise value | $954.59M+198% | $827.34M-50.9% | $1.68B-52.4% | $3.54B-82.6% | |
| Price / sales | 4.2×+3.0× | 3×-2.7× | 5.7×+1.6× | 4.1×-21.4× | |
| Price / book | 4.3×+3.3× | 2.4×-1.6× | 4×-2.6× | 6.6×-58.0× | |
| EV / sales | 4.9×+3.5× | 3.2×-2.6× | 5.8×+1.8× | 4×-21.5× | |
| Free cash flow yield | -5.8%— | —— | —— | 14.5%+12.7pp | |
| Earnings yield | -11.6%+43.3pp | -18.7%-11.5pp | -7.2%-13.4pp | 6.1%+5.2pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Maravai LifeSciences Holdings, Inc.'s profit margins?
- Maravai LifeSciences Holdings, Inc. (MRVI) runs a 29.3% gross margin and a -82.2% operating margin, with a -51.1% net margin.
- Where do Maravai LifeSciences Holdings, Inc.'s ratios come from?
- Every ratio is computed from Maravai LifeSciences Holdings, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
